Primary Job Title Board of Directors Primary Organization OPMEDIC
Gender Male
LinkedIn View on LinkedIn
Ken Newport was appointed to Jennerex's board in 2007. A chartered accountant, entrepreneur and life sciences business executive, Mr. Newport served as senior vice president and executive committee member at PRA International Inc. for three years until his retirement in 2005. In the mid-nineties he was co-founder and president of CroMedica
Inc., a clinical trials contract research organization which was sold to PRA International in 2002.
Mr. Newport was also a founding member of Global Biomedical Capital Corporation, Zelos Therapeutics Inc., Prime Trials Inc. and other life science organizations. He is a member of the Institute of Corporate Directors and also serves on the corporate boards of The Opmedic Group and Medgenesis Therapeutics Inc.
Mr. Newport earned Honours B.A. and Masters of Accounting degrees from the University of Waterloo.